Jean Gariépy
Directeur Technique/Scientifique/R&D chez Ontario Cancer Institute
Profil
Jean Gariépy is the founder of Molecular Templates, Inc. which was founded in 2000.
He also held the title of Chief Scientific Officer at Molecular Templates, Inc. in 2009.
Dr. Gariépy's current jobs include being a Professor at the University of Toronto and a Senior Scientist at the Ontario Cancer Institute since 2009.
He previously worked as a Principal at the Princess Margaret Hospital Foundation.
Dr. Gariépy obtained a doctorate degree from the University of Alberta.
Postes actifs de Jean Gariépy
| Sociétés | Poste | Début |
|---|---|---|
| University of Toronto | Corporate Officer/Principal | - |
| Ontario Cancer Institute | Directeur Technique/Scientifique/R&D | 02/09/2009 |
Anciens postes connus de Jean Gariépy
| Sociétés | Poste | Fin |
|---|---|---|
| Princess Margaret Hospital Foundation | Corporate Officer/Principal | - |
| MOLECULAR TEMPLATES, INC. | Fondateur | - |
Molecular Templates, Inc. /Old/
 Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX. | Fondateur | - |
Formation de Jean Gariépy
| University of Alberta | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MOLECULAR TEMPLATES, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Molecular Templates, Inc. /Old/
Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX. | Health Technology |
| Princess Margaret Hospital Foundation | |
| Ontario Cancer Institute |
